Pharmacovigilance and Drug Safety Software Market Growth, Demand and Challenges of the Key Industry Players

1
Global Pharmacovigilance and Drug Safety Software
Market Research and Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Pharmacovigilance and Drug Safety
Software Market Research Report 2022-2027 The
latest report by IMARC Group, titled Pharmacovigi
lance and Drug Safety Software Market Global
Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2022-2027, finds that the global
pharmacovigilance and drug safety software
market reached a value of US 176.6 Million in
2021. Pharmacovigilance (PV) and drug safety
software is a management solution that enables
the creation, classification, review, submission,
and maintenance of PV data and adverse event
reports. The process involves monitoring medical
drug effects to identify and examine the
unfavorable reactions of the drugs. It creates
more knowledge and awareness among healthcare
professionals. PV and drug safety software offers
swift science-based safety decisions, ensures
global regulatory compliance, integrates safety
and risk management, and lowers the cost of PV
procedures. As a result, the software is
extensively employed by pharma and biotech
companies, contract research organizations
(CROs), business process outsourcing firms
(BPOs), and other PV service providers. Request
for a PDF sample of this report
https//www.imarcgroup.com/pharmacovigilance-drug-
safety-software-market/requestsample

4
Report Description and Highlights
Report Description
Global Pharmacovigilance and Drug Safety
Software Market Trends The market is primarily
driven by the growing adoption of PV and drug
safety software by various clinical research and
outsourcing companies. The rising prevalence of
chronic diseases, coupled with the increasing
incidence rates of adverse drug reactions (ADRs),
are also fueling the growth of the market. In
addition to this, the easy adoption of the
software due to the availability of cutting-edge
technology is also propelling the market growth.
Governments across various countries are
imposing strict regulations for the
commercialization of drugs. Consequently, the
growing complexity related to drug safety
regulations is also propelling the market growth.
Furthermore, rapid digitization of clinical
trials, along with the adoption of advanced
technologies that improve compliance and product
safety in PV and drug safety software, is
creating a positive outlook for the market.
Looking forward, the market is expected to
reach a value of US 265 Million by 2027,
exhibiting a CAGR of 6.60 during the forecast
period (2022-2027). View Report TOC, Figures and
Tables https//www.imarcgroup.com/pharmacovigilan
ce-drug-safety-software-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Functionality
• Adverse Event Reporting Softwar
• Drug Safety Audits Software
• Issue Tracking Software
• Fully Integrated Software
•  
• Breakup by Delivery Mode
• On-premises
• Cloud-based
• Breakup by End User
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Business Process Outsourcing Firms
• Others

6
Report Description and Highlights
Report Description

•  
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
• Competitive Landscape with Key Players
• Ab Cube
• Anju Software Inc.
• ArisGlobal LLC
• Cognizant
• Ennov Solutions Inc.
• Extedo GmbH
• Max Application
• Oracle Corporation
• Sarjen Systems Pvt Ltd
• Sparta Systems Inc. (Honeywell International
  Inc.)

7
Key Questions Answered in the Report
Report Description

• How has the global pharmacovigilance and drug
  safety software market performed so far and how
  will it perform in the coming years?
• What has been the impact of COVID-19 on the
  global pharmacovigilance and drug safety software
  market?
• What are the key regional markets?
• What is the breakup of the market based on the
  functionality?
• What is the breakup of the market based on the
  delivery mode?
• What is the breakup of the market based on the
  end user?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global
  pharmacovigilance and drug safety software market
  and who are the key players?
• What is the degree of competition in the
  industry?
•  

8
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1  
  Objectives of the Study    2.2    Stakeholders
    2.3    Data Sources        2.3.1   Primary
Sources        2.3.2   Secondary
Sources    2.4    Market Estimation        2.4.1
   Bottom-Up Approach        2.4.2   Top-Down
Approach    2.5    Forecasting
Methodology3    Executive Summary4    Introducti
on    4.1    Overview    4.2    Key Industry
Trends5    Global Pharmacovigilance and Drug
Safety Software Market    5.1    Market
Overview    5.2    Market Performance    5.3    
Impact of COVID-19    5.4    Market Forecast

9
Table of Contents
Report Description
6    Market Breakup by Functionality    6.1    A
dverse Event Reporting Software        6.1.1 Mark
et Trends        6.1.2 Market Forecast    6.2   
 Drug Safety Audits Software        6.2.1 Market
Trends        6.2.2 Market Forecast    6.3    Is
sue Tracking Software        6.3.1 Market
Trends        6.3.2 Market Forecast    6.4    Fu
lly Integrated Software        6.4.1 Market
Trends        6.4.2 Market Forecast7    Market
Breakup by Delivery Mode    7.1    On-premises  
      7.1.1 Market Trends          Click here
to visit the complete table of content with list
of figures and tables https//www.imarcgroup.com/
pharmacovigilance-drug-safety-software-market/toc

10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us